Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.
ABMD
ABIOMED INCData as of 2022 Q3 (09-30) · 13F snapshot
Summary
ABIOMED INC (ABMD) is held by 9 tracked hedge-fund managers, a combined reported value of ~$451.15M; the largest are Renaissance Technologies, Chase Coleman, Andreas Halvorsen. 12 members of Congress have disclosed STOCK Act trades. Data as of 2022 Q3, from public SEC 13F filings, delayed up to ~45 days.
Attention · HighThis quarter · Quiet
Gurus holding9
Congress trades12
Price—no price
Sectors0
This quarter's moves
Top holderRenaissance TechnologiesNew0
Added0
Trimmed / sold0
Chase ColemanHold
Value $41.96M0.6% of portfolio1,690,0002014 Q3
Value $16.70M— of portfolio68,0002022 Q3
Value $6.46M— of portfolio26,3002022 Q3
Value $3.51M— of portfolio14,3002022 Q3
Value $1.63M— of portfolio5,0002021 Q3
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Chase Coleman | $41.96M | 0.6% | Hold |
| Izzy EnglanderCALL | $16.70M | — | — |
| Ken GriffinCALL | $6.46M | — | — |
| Ken GriffinPUT | $3.51M | — | — |
| Izzy EnglanderPUT | $1.63M | — | — |